Gresham Richter
Concepts (606)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Malformations | 25 | 2025 | 105 | 7.580 |
Why?
| | Arteriovenous Malformations | 19 | 2024 | 75 | 7.250 |
Why?
| | Hemangioma | 16 | 2025 | 86 | 5.980 |
Why?
| | Propranolol | 11 | 2025 | 77 | 3.750 |
Why?
| | Glottis | 9 | 2024 | 34 | 3.600 |
Why?
| | Laryngomalacia | 10 | 2024 | 25 | 3.510 |
Why?
| | Lymphatic Abnormalities | 8 | 2025 | 23 | 3.050 |
Why?
| | Infant | 56 | 2025 | 3808 | 2.430 |
Why?
| | Neck | 12 | 2022 | 97 | 2.050 |
Why?
| | Child | 61 | 2025 | 7384 | 1.990 |
Why?
| | Child, Preschool | 49 | 2025 | 4164 | 1.930 |
Why?
| | Humans | 136 | 2025 | 53246 | 1.800 |
Why?
| | Sclerotherapy | 12 | 2023 | 47 | 1.780 |
Why?
| | Lasers, Solid-State | 5 | 2020 | 31 | 1.720 |
Why?
| | Treatment Outcome | 39 | 2025 | 5597 | 1.650 |
Why?
| | Laryngoscopy | 10 | 2020 | 60 | 1.620 |
Why?
| | Deglutition Disorders | 5 | 2017 | 76 | 1.610 |
Why?
| | Ambulatory Surgical Procedures | 3 | 2024 | 54 | 1.600 |
Why?
| | Laryngostenosis | 4 | 2020 | 12 | 1.600 |
Why?
| | Laser Therapy | 6 | 2020 | 75 | 1.430 |
Why?
| | Laryngoplasty | 2 | 2024 | 8 | 1.410 |
Why?
| | Male | 81 | 2025 | 27444 | 1.320 |
Why?
| | Vascular Surgical Procedures | 5 | 2020 | 171 | 1.310 |
Why?
| | Embolization, Therapeutic | 8 | 2023 | 91 | 1.270 |
Why?
| | Otolaryngology | 6 | 2025 | 62 | 1.260 |
Why?
| | Female | 79 | 2025 | 28792 | 1.240 |
Why?
| | Larynx | 7 | 2017 | 30 | 1.170 |
Why?
| | Tonsillectomy | 4 | 2021 | 50 | 1.170 |
Why?
| | Veins | 6 | 2023 | 74 | 1.160 |
Why?
| | Hemangioma, Capillary | 2 | 2020 | 12 | 1.130 |
Why?
| | Retrospective Studies | 35 | 2024 | 6821 | 1.110 |
Why?
| | Head | 6 | 2022 | 73 | 1.060 |
Why?
| | Skin | 7 | 2020 | 420 | 0.960 |
Why?
| | Cell Proliferation | 8 | 2025 | 1031 | 0.950 |
Why?
| | Trachea | 5 | 2018 | 55 | 0.850 |
Why?
| | Head and Neck Neoplasms | 6 | 2015 | 292 | 0.850 |
Why?
| | Heart Bypass, Right | 1 | 2024 | 13 | 0.840 |
Why?
| | Arteriovenous Fistula | 1 | 2024 | 28 | 0.830 |
Why?
| | Blood Proteins | 1 | 2024 | 84 | 0.820 |
Why?
| | Pulmonary Veins | 1 | 2024 | 41 | 0.820 |
Why?
| | Adolescent | 31 | 2024 | 6912 | 0.810 |
Why?
| | Facial Neoplasms | 2 | 2017 | 22 | 0.810 |
Why?
| | Tongue | 4 | 2023 | 40 | 0.800 |
Why?
| | Fontan Procedure | 1 | 2024 | 67 | 0.800 |
Why?
| | Pulmonary Artery | 2 | 2024 | 142 | 0.800 |
Why?
| | Vocal Cord Paralysis | 2 | 2022 | 23 | 0.800 |
Why?
| | Collagen | 4 | 2019 | 215 | 0.790 |
Why?
| | Surgery, Computer-Assisted | 3 | 2020 | 54 | 0.790 |
Why?
| | Otorhinolaryngologic Diseases | 2 | 2014 | 12 | 0.780 |
Why?
| | Endothelial Cells | 5 | 2025 | 289 | 0.750 |
Why?
| | Infant, Newborn | 20 | 2024 | 2913 | 0.750 |
Why?
| | Proteome | 1 | 2024 | 178 | 0.750 |
Why?
| | Face | 2 | 2020 | 56 | 0.740 |
Why?
| | Health Information Systems | 1 | 2022 | 18 | 0.730 |
Why?
| | Nitric Oxide Synthase Type III | 3 | 2013 | 83 | 0.720 |
Why?
| | Respiratory Aspiration | 2 | 2014 | 8 | 0.720 |
Why?
| | Adrenergic beta-Antagonists | 4 | 2020 | 108 | 0.710 |
Why?
| | Hyperpigmentation | 1 | 2021 | 10 | 0.700 |
Why?
| | Proteomics | 1 | 2024 | 337 | 0.700 |
Why?
| | Cricoid Cartilage | 2 | 2020 | 10 | 0.690 |
Why?
| | Receptors, Progesterone | 1 | 2021 | 68 | 0.660 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 3 | 2014 | 34 | 0.660 |
Why?
| | Ambulatory Care Facilities | 1 | 2021 | 121 | 0.650 |
Why?
| | Graft Survival | 4 | 2011 | 158 | 0.650 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2019 | 33 | 0.640 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2020 | 35 | 0.640 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 134 | 0.640 |
Why?
| | Prospective Studies | 9 | 2022 | 2412 | 0.640 |
Why?
| | Dilatation | 2 | 2017 | 28 | 0.630 |
Why?
| | Risk Assessment | 10 | 2018 | 1368 | 0.620 |
Why?
| | Tracheostomy | 3 | 2022 | 76 | 0.600 |
Why?
| | Vasodilator Agents | 2 | 2017 | 90 | 0.590 |
Why?
| | Elastin | 1 | 2019 | 24 | 0.590 |
Why?
| | Inpatients | 1 | 2021 | 208 | 0.590 |
Why?
| | Follow-Up Studies | 15 | 2018 | 2318 | 0.590 |
Why?
| | Estradiol | 3 | 2018 | 215 | 0.580 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1112 | 0.580 |
Why?
| | Skin Transplantation | 3 | 2009 | 43 | 0.580 |
Why?
| | Gastroesophageal Reflux | 2 | 2017 | 51 | 0.580 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2009 | 189 | 0.570 |
Why?
| | Thyroid Cartilage | 1 | 2018 | 3 | 0.560 |
Why?
| | Pharynx | 3 | 2014 | 31 | 0.560 |
Why?
| | Vascular Neoplasms | 1 | 2018 | 17 | 0.560 |
Why?
| | Mast Cells | 1 | 2018 | 56 | 0.550 |
Why?
| | Postoperative Complications | 5 | 2024 | 1099 | 0.550 |
Why?
| | Endoscopy | 6 | 2015 | 128 | 0.550 |
Why?
| | Ki-67 Antigen | 3 | 2013 | 57 | 0.530 |
Why?
| | Endovascular Procedures | 1 | 2020 | 193 | 0.530 |
Why?
| | Disease Models, Animal | 2 | 2013 | 1517 | 0.520 |
Why?
| | Young Adult | 13 | 2024 | 4514 | 0.520 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 112 | 0.520 |
Why?
| | Respiratory Tract Infections | 2 | 2020 | 82 | 0.520 |
Why?
| | Deglutition | 3 | 2014 | 45 | 0.520 |
Why?
| | Adult | 32 | 2024 | 14541 | 0.510 |
Why?
| | Rectum | 1 | 2017 | 55 | 0.510 |
Why?
| | Vagina | 1 | 2017 | 45 | 0.500 |
Why?
| | Eosinophilic Esophagitis | 1 | 2017 | 44 | 0.500 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2017 | 44 | 0.500 |
Why?
| | Ultrasonography, Prenatal | 1 | 2018 | 151 | 0.500 |
Why?
| | Renin-Angiotensin System | 1 | 2017 | 58 | 0.500 |
Why?
| | Laryngeal Neoplasms | 2 | 2015 | 44 | 0.500 |
Why?
| | Wound Healing | 4 | 2014 | 226 | 0.490 |
Why?
| | Bleomycin | 3 | 2022 | 38 | 0.490 |
Why?
| | Cerebral Palsy | 2 | 2014 | 36 | 0.480 |
Why?
| | Skin Neoplasms | 2 | 2022 | 500 | 0.480 |
Why?
| | Nasopharynx | 2 | 2020 | 34 | 0.470 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 58 | 0.470 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2016 | 88 | 0.460 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2014 | 70 | 0.460 |
Why?
| | Hearing Aids | 5 | 2017 | 72 | 0.450 |
Why?
| | Blotting, Western | 4 | 2021 | 587 | 0.440 |
Why?
| | Blood Coagulation Disorders | 3 | 2020 | 41 | 0.430 |
Why?
| | Skin Ulcer | 1 | 2014 | 9 | 0.420 |
Why?
| | Alginates | 1 | 2014 | 12 | 0.420 |
Why?
| | Signal Transduction | 4 | 2025 | 1748 | 0.420 |
Why?
| | Polysaccharides | 1 | 2014 | 57 | 0.410 |
Why?
| | Silver | 1 | 2014 | 49 | 0.410 |
Why?
| | Adenoidectomy | 2 | 2020 | 36 | 0.410 |
Why?
| | Organophosphonates | 1 | 2013 | 6 | 0.400 |
Why?
| | Periodicals as Topic | 1 | 2014 | 63 | 0.400 |
Why?
| | Cytosine | 1 | 2013 | 30 | 0.390 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 16 | 0.390 |
Why?
| | RNA, Messenger | 4 | 2022 | 1133 | 0.390 |
Why?
| | Nervous System Diseases | 1 | 2014 | 93 | 0.390 |
Why?
| | Palate | 1 | 2013 | 12 | 0.380 |
Why?
| | Uvula | 1 | 2013 | 13 | 0.380 |
Why?
| | Gestational Age | 3 | 2013 | 394 | 0.380 |
Why?
| | Choristoma | 1 | 2013 | 22 | 0.380 |
Why?
| | Pharyngeal Diseases | 1 | 2013 | 16 | 0.380 |
Why?
| | Infant, Premature, Diseases | 1 | 2013 | 97 | 0.370 |
Why?
| | Surgical Flaps | 2 | 2020 | 110 | 0.370 |
Why?
| | Thymus Gland | 1 | 2013 | 39 | 0.370 |
Why?
| | Consensus | 5 | 2024 | 206 | 0.370 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 109 | 0.360 |
Why?
| | Comorbidity | 4 | 2024 | 638 | 0.360 |
Why?
| | Quality of Life | 3 | 2014 | 902 | 0.360 |
Why?
| | Milk Hypersensitivity | 1 | 2012 | 19 | 0.360 |
Why?
| | Down Syndrome | 1 | 2013 | 95 | 0.360 |
Why?
| | Pilot Projects | 4 | 2019 | 727 | 0.360 |
Why?
| | Lymphangioma, Cystic | 1 | 2011 | 9 | 0.350 |
Why?
| | Otitis Media with Effusion | 2 | 2025 | 20 | 0.350 |
Why?
| | Endothelium, Lymphatic | 1 | 2011 | 8 | 0.350 |
Why?
| | Clinical Competence | 3 | 2020 | 406 | 0.350 |
Why?
| | Antigens, CD | 1 | 2013 | 217 | 0.350 |
Why?
| | Delphi Technique | 5 | 2024 | 71 | 0.350 |
Why?
| | Laryngeal Diseases | 2 | 2010 | 12 | 0.340 |
Why?
| | Milk Proteins | 1 | 2012 | 77 | 0.340 |
Why?
| | Microtubule-Associated Proteins | 1 | 2011 | 61 | 0.340 |
Why?
| | Mouth | 2 | 2010 | 36 | 0.340 |
Why?
| | Papillomavirus Infections | 1 | 2013 | 177 | 0.340 |
Why?
| | Homeodomain Proteins | 1 | 2011 | 81 | 0.340 |
Why?
| | Tracheoesophageal Fistula | 2 | 2008 | 11 | 0.340 |
Why?
| | Combined Modality Therapy | 7 | 2018 | 640 | 0.340 |
Why?
| | Laryngeal Mucosa | 1 | 2011 | 4 | 0.330 |
Why?
| | Laryngeal Nerves | 1 | 2011 | 15 | 0.330 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2010 | 9 | 0.330 |
Why?
| | Magnetic Resonance Angiography | 3 | 2018 | 72 | 0.330 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 130 | 0.330 |
Why?
| | Osseointegration | 3 | 2017 | 25 | 0.330 |
Why?
| | Severity of Illness Index | 6 | 2014 | 1049 | 0.320 |
Why?
| | Neuromuscular Diseases | 1 | 2011 | 31 | 0.320 |
Why?
| | Hospitals, Special | 1 | 2010 | 9 | 0.320 |
Why?
| | Airway Obstruction | 3 | 2018 | 49 | 0.320 |
Why?
| | Cholesteatoma, Middle Ear | 2 | 2009 | 32 | 0.310 |
Why?
| | Capillaries | 2 | 2022 | 53 | 0.310 |
Why?
| | Cheek | 1 | 2010 | 9 | 0.310 |
Why?
| | Lip | 1 | 2010 | 11 | 0.310 |
Why?
| | Immunohistochemistry | 4 | 2015 | 975 | 0.300 |
Why?
| | Tracheal Neoplasms | 1 | 2009 | 8 | 0.300 |
Why?
| | Fibrin Tissue Adhesive | 2 | 2008 | 13 | 0.300 |
Why?
| | Tympanic Membrane | 2 | 2025 | 41 | 0.300 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2009 | 5 | 0.300 |
Why?
| | Tomography, X-Ray Computed | 7 | 2015 | 1183 | 0.300 |
Why?
| | Cicatrix | 2 | 2020 | 43 | 0.300 |
Why?
| | Carcinoma, Medullary | 1 | 2009 | 12 | 0.300 |
Why?
| | Proteus mirabilis | 1 | 2009 | 2 | 0.290 |
Why?
| | Proteus Infections | 1 | 2009 | 4 | 0.290 |
Why?
| | Bacteroidaceae Infections | 1 | 2009 | 4 | 0.290 |
Why?
| | Electrocoagulation | 2 | 2009 | 12 | 0.290 |
Why?
| | Bacteroides | 1 | 2009 | 14 | 0.290 |
Why?
| | Brain Abscess | 1 | 2009 | 10 | 0.290 |
Why?
| | Otitis Media, Suppurative | 1 | 2009 | 8 | 0.290 |
Why?
| | Cerebellar Diseases | 1 | 2009 | 17 | 0.290 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2009 | 33 | 0.290 |
Why?
| | Vomiting | 2 | 2021 | 71 | 0.290 |
Why?
| | Quality Improvement | 2 | 2021 | 230 | 0.290 |
Why?
| | Injections, Intralesional | 3 | 2021 | 32 | 0.280 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2021 | 181 | 0.280 |
Why?
| | Time Factors | 7 | 2020 | 2992 | 0.280 |
Why?
| | Risk Factors | 9 | 2020 | 4018 | 0.280 |
Why?
| | Child Development | 1 | 2010 | 215 | 0.280 |
Why?
| | Electrosurgery | 1 | 2008 | 10 | 0.270 |
Why?
| | Tracheotomy | 2 | 2019 | 15 | 0.270 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 113 | 0.270 |
Why?
| | MicroRNAs | 2 | 2023 | 397 | 0.260 |
Why?
| | Skin, Artificial | 1 | 2007 | 11 | 0.260 |
Why?
| | Hearing Loss, Unilateral | 3 | 2013 | 13 | 0.260 |
Why?
| | Fasciitis, Necrotizing | 1 | 2006 | 7 | 0.250 |
Why?
| | Atlanto-Axial Joint | 1 | 2006 | 8 | 0.250 |
Why?
| | Pediatrics | 3 | 2025 | 307 | 0.250 |
Why?
| | Emphysema | 1 | 2006 | 14 | 0.250 |
Why?
| | Diet | 1 | 2010 | 611 | 0.240 |
Why?
| | Arytenoid Cartilage | 2 | 2020 | 4 | 0.240 |
Why?
| | Photography | 2 | 2020 | 32 | 0.240 |
Why?
| | Recurrence | 6 | 2016 | 694 | 0.240 |
Why?
| | Disease Management | 3 | 2019 | 187 | 0.240 |
Why?
| | Angiopoietin-2 | 1 | 2025 | 17 | 0.230 |
Why?
| | Otoscopes | 1 | 2025 | 5 | 0.230 |
Why?
| | Bone Conduction | 3 | 2017 | 26 | 0.230 |
Why?
| | Tinnitus | 1 | 2006 | 64 | 0.230 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2006 | 72 | 0.230 |
Why?
| | Esophagus | 3 | 2020 | 83 | 0.230 |
Why?
| | Esophagoscopy | 2 | 2020 | 29 | 0.230 |
Why?
| | Reoperation | 6 | 2014 | 476 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 4 | 2019 | 533 | 0.230 |
Why?
| | Radiography | 2 | 2018 | 476 | 0.220 |
Why?
| | Animals | 13 | 2025 | 13528 | 0.220 |
Why?
| | Branchial Region | 1 | 2024 | 4 | 0.210 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 1003 | 0.210 |
Why?
| | Myringoplasty | 1 | 2024 | 6 | 0.210 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 56 | 0.210 |
Why?
| | Middle Aged | 16 | 2024 | 13422 | 0.210 |
Why?
| | Tympanic Membrane Perforation | 1 | 2024 | 20 | 0.210 |
Why?
| | Artificial Intelligence | 1 | 2025 | 131 | 0.200 |
Why?
| | Fellowships and Scholarships | 2 | 2016 | 124 | 0.200 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 1723 | 0.200 |
Why?
| | Diagnostic Imaging | 2 | 2017 | 176 | 0.200 |
Why?
| | Internship and Residency | 2 | 2020 | 439 | 0.200 |
Why?
| | Single-Blind Method | 2 | 2020 | 120 | 0.200 |
Why?
| | Patient Selection | 2 | 2019 | 273 | 0.200 |
Why?
| | Cohort Studies | 5 | 2020 | 1557 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 5 | 2015 | 1587 | 0.190 |
Why?
| | Antigens, Nuclear | 2 | 2013 | 23 | 0.190 |
Why?
| | Treatment Failure | 2 | 2016 | 119 | 0.190 |
Why?
| | Prognosis | 4 | 2018 | 2118 | 0.190 |
Why?
| | Transplantation, Heterologous | 2 | 2013 | 78 | 0.190 |
Why?
| | Mandible | 1 | 2023 | 25 | 0.190 |
Why?
| | Esthetics, Dental | 1 | 2022 | 5 | 0.190 |
Why?
| | Tracheal Stenosis | 2 | 2015 | 14 | 0.180 |
Why?
| | Vocal Cords | 1 | 2022 | 9 | 0.180 |
Why?
| | Mice, Nude | 2 | 2013 | 232 | 0.180 |
Why?
| | Middle Ear Ventilation | 2 | 2025 | 20 | 0.180 |
Why?
| | Disease Progression | 3 | 2011 | 880 | 0.180 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2022 | 61 | 0.180 |
Why?
| | Length of Stay | 2 | 2024 | 684 | 0.180 |
Why?
| | Patient Readmission | 1 | 2024 | 251 | 0.180 |
Why?
| | Immunoenzyme Techniques | 2 | 2013 | 134 | 0.180 |
Why?
| | Nevus, Blue | 1 | 2022 | 11 | 0.180 |
Why?
| | Respiratory Sounds | 2 | 2019 | 51 | 0.180 |
Why?
| | Databases, Factual | 1 | 2025 | 742 | 0.170 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2022 | 44 | 0.170 |
Why?
| | Mice | 5 | 2025 | 5982 | 0.170 |
Why?
| | Case-Control Studies | 2 | 2017 | 1212 | 0.170 |
Why?
| | Rats, Sprague-Dawley | 5 | 2009 | 1544 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2013 | 1367 | 0.170 |
Why?
| | Operating Rooms | 1 | 2021 | 27 | 0.170 |
Why?
| | Nausea | 1 | 2021 | 43 | 0.170 |
Why?
| | Efficiency, Organizational | 1 | 2021 | 42 | 0.160 |
Why?
| | Air Microbiology | 1 | 2020 | 12 | 0.160 |
Why?
| | Mouth Mucosa | 1 | 2020 | 27 | 0.160 |
Why?
| | Thrombelastography | 1 | 2020 | 27 | 0.160 |
Why?
| | DiGeorge Syndrome | 1 | 2020 | 18 | 0.160 |
Why?
| | Hemostasis | 1 | 2020 | 55 | 0.160 |
Why?
| | Reference Values | 2 | 2011 | 311 | 0.160 |
Why?
| | Diagnosis, Differential | 3 | 2019 | 1038 | 0.160 |
Why?
| | LIM Domain Proteins | 1 | 2020 | 8 | 0.160 |
Why?
| | Retinal Dehydrogenase | 1 | 2020 | 10 | 0.160 |
Why?
| | Myosin Type I | 1 | 2020 | 5 | 0.160 |
Why?
| | Antiporters | 1 | 2020 | 19 | 0.160 |
Why?
| | Receptors, Notch | 1 | 2020 | 28 | 0.160 |
Why?
| | Hearing Loss, Conductive | 2 | 2011 | 55 | 0.160 |
Why?
| | Mastoid | 3 | 2009 | 51 | 0.150 |
Why?
| | Cytoskeletal Proteins | 1 | 2020 | 46 | 0.150 |
Why?
| | Parasomnias | 1 | 2019 | 4 | 0.150 |
Why?
| | Pain, Postoperative | 1 | 2021 | 169 | 0.150 |
Why?
| | Analysis of Variance | 2 | 2014 | 547 | 0.150 |
Why?
| | Microsurgery | 2 | 2011 | 32 | 0.150 |
Why?
| | Surgical Wound Infection | 1 | 2020 | 118 | 0.150 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 86 | 0.150 |
Why?
| | Physician Assistants | 1 | 2019 | 19 | 0.150 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 42 | 0.150 |
Why?
| | Tetralogy of Fallot | 1 | 2020 | 83 | 0.150 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 90 | 0.150 |
Why?
| | Neovascularization, Pathologic | 1 | 2020 | 158 | 0.150 |
Why?
| | Endothelium, Vascular | 1 | 2021 | 262 | 0.150 |
Why?
| | Ambulatory Care | 1 | 2021 | 239 | 0.150 |
Why?
| | Elastic Tissue | 1 | 2019 | 10 | 0.150 |
Why?
| | Age Factors | 4 | 2013 | 1136 | 0.150 |
Why?
| | Professional Role | 1 | 2019 | 85 | 0.150 |
Why?
| | Microcirculation | 1 | 2019 | 63 | 0.150 |
Why?
| | Nurse Practitioners | 1 | 2019 | 43 | 0.140 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2019 | 65 | 0.140 |
Why?
| | Rats | 5 | 2009 | 3164 | 0.140 |
Why?
| | Tryptases | 1 | 2018 | 4 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 202 | 0.140 |
Why?
| | Sirolimus | 1 | 2019 | 72 | 0.140 |
Why?
| | Dexamethasone | 1 | 2021 | 429 | 0.140 |
Why?
| | p120 GTPase Activating Protein | 1 | 2018 | 1 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 625 | 0.140 |
Why?
| | Fibrosis | 1 | 2019 | 198 | 0.140 |
Why?
| | Port-Wine Stain | 1 | 2018 | 14 | 0.140 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 54 | 0.140 |
Why?
| | Constriction, Pathologic | 1 | 2018 | 91 | 0.140 |
Why?
| | Cryosurgery | 1 | 2018 | 36 | 0.140 |
Why?
| | Airway Extubation | 1 | 2018 | 30 | 0.140 |
Why?
| | Random Allocation | 2 | 2009 | 284 | 0.140 |
Why?
| | Estrogen Receptor alpha | 1 | 2018 | 85 | 0.140 |
Why?
| | Protein Transport | 1 | 2018 | 168 | 0.140 |
Why?
| | Algorithms | 2 | 2025 | 668 | 0.140 |
Why?
| | Ultrasonography, Doppler | 1 | 2018 | 42 | 0.130 |
Why?
| | Optical Phenomena | 1 | 2017 | 5 | 0.130 |
Why?
| | Nanomedicine | 1 | 2017 | 15 | 0.130 |
Why?
| | Palatine Tonsil | 1 | 2017 | 11 | 0.130 |
Why?
| | Neovascularization, Physiologic | 2 | 2009 | 86 | 0.130 |
Why?
| | Faculty, Medical | 2 | 2019 | 92 | 0.130 |
Why?
| | Cadaver | 1 | 2017 | 90 | 0.130 |
Why?
| | beta-Thromboglobulin | 1 | 2017 | 1 | 0.130 |
Why?
| | Aggressive Periodontitis | 1 | 2017 | 1 | 0.130 |
Why?
| | Platelet Factor 4 | 1 | 2017 | 2 | 0.130 |
Why?
| | Constipation | 1 | 2017 | 37 | 0.130 |
Why?
| | Chemokine CXCL5 | 1 | 2017 | 7 | 0.130 |
Why?
| | Pressure | 1 | 2017 | 102 | 0.130 |
Why?
| | Angiotensinogen | 1 | 2017 | 12 | 0.130 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 116 | 0.130 |
Why?
| | Pathology, Surgical | 1 | 2017 | 23 | 0.130 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2017 | 27 | 0.130 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2018 | 84 | 0.130 |
Why?
| | Transcriptome | 1 | 2020 | 368 | 0.130 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2017 | 56 | 0.130 |
Why?
| | Diarrhea | 1 | 2017 | 96 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 181 | 0.120 |
Why?
| | Aged | 10 | 2022 | 10430 | 0.120 |
Why?
| | Child Behavior Disorders | 1 | 2017 | 77 | 0.120 |
Why?
| | Apoptosis | 3 | 2020 | 1139 | 0.120 |
Why?
| | Child Behavior | 1 | 2017 | 110 | 0.120 |
Why?
| | Food Hypersensitivity | 1 | 2017 | 107 | 0.120 |
Why?
| | Serum | 1 | 2016 | 32 | 0.120 |
Why?
| | Tobacco Smoke Pollution | 1 | 2016 | 56 | 0.120 |
Why?
| | Mitochondria | 1 | 2020 | 447 | 0.120 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 370 | 0.120 |
Why?
| | Nasopharyngeal Diseases | 1 | 2015 | 3 | 0.110 |
Why?
| | Hearing Loss | 1 | 2017 | 99 | 0.110 |
Why?
| | Nasal Obstruction | 1 | 2015 | 12 | 0.110 |
Why?
| | Anticoagulants | 1 | 2018 | 280 | 0.110 |
Why?
| | Urinary Bladder | 1 | 2015 | 101 | 0.110 |
Why?
| | Inflammation | 1 | 2019 | 653 | 0.110 |
Why?
| | Bandages, Hydrocolloid | 1 | 2014 | 5 | 0.110 |
Why?
| | Gels | 1 | 2014 | 22 | 0.110 |
Why?
| | Endoscopy, Digestive System | 1 | 2014 | 51 | 0.110 |
Why?
| | Biopsy, Needle | 1 | 2015 | 181 | 0.100 |
Why?
| | North America | 1 | 2014 | 75 | 0.100 |
Why?
| | Early Diagnosis | 1 | 2014 | 84 | 0.100 |
Why?
| | Foreign Bodies | 2 | 2020 | 66 | 0.100 |
Why?
| | Sickness Impact Profile | 1 | 2014 | 28 | 0.100 |
Why?
| | Administration, Oral | 2 | 2018 | 456 | 0.100 |
Why?
| | Term Birth | 1 | 2013 | 16 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 38 | 0.100 |
Why?
| | Hospitals, University | 1 | 2013 | 75 | 0.090 |
Why?
| | Angiography | 3 | 2007 | 114 | 0.090 |
Why?
| | Polysomnography | 1 | 2013 | 76 | 0.090 |
Why?
| | Actins | 1 | 2013 | 114 | 0.090 |
Why?
| | Otologic Surgical Procedures | 2 | 2009 | 37 | 0.090 |
Why?
| | Pregnancy | 1 | 2019 | 2610 | 0.090 |
Why?
| | Bronchoscopy | 2 | 2010 | 78 | 0.090 |
Why?
| | Incidence | 2 | 2013 | 1085 | 0.090 |
Why?
| | Gene Transfer Techniques | 2 | 2002 | 44 | 0.090 |
Why?
| | Bone Neoplasms | 1 | 1994 | 188 | 0.090 |
Why?
| | Antiviral Agents | 1 | 2013 | 179 | 0.090 |
Why?
| | Lymphocele | 1 | 2011 | 7 | 0.090 |
Why?
| | Tissue Survival | 1 | 2011 | 10 | 0.090 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2013 | 82 | 0.090 |
Why?
| | Statistics, Nonparametric | 2 | 2014 | 198 | 0.090 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 46 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 42 | 0.090 |
Why?
| | Ultrasonography, Interventional | 1 | 2012 | 138 | 0.090 |
Why?
| | Education, Medical, Graduate | 1 | 2014 | 219 | 0.090 |
Why?
| | Internet | 1 | 2014 | 265 | 0.090 |
Why?
| | Liver | 1 | 2017 | 1150 | 0.080 |
Why?
| | Arkansas | 3 | 2016 | 2068 | 0.080 |
Why?
| | Lymphocytosis | 1 | 2011 | 4 | 0.080 |
Why?
| | Laryngeal Edema | 1 | 2011 | 5 | 0.080 |
Why?
| | Genetic Therapy | 2 | 2002 | 127 | 0.080 |
Why?
| | Brain | 1 | 2019 | 1353 | 0.080 |
Why?
| | Hypertrophy | 1 | 2011 | 53 | 0.080 |
Why?
| | Nutritional Support | 1 | 2010 | 31 | 0.080 |
Why?
| | Infant, Premature | 1 | 2013 | 331 | 0.080 |
Why?
| | Fetus | 3 | 2021 | 191 | 0.080 |
Why?
| | Lip Neoplasms | 1 | 2010 | 3 | 0.080 |
Why?
| | Burns | 2 | 2002 | 164 | 0.080 |
Why?
| | Auditory Threshold | 1 | 2010 | 54 | 0.080 |
Why?
| | Tracheal Diseases | 1 | 2010 | 13 | 0.080 |
Why?
| | Hospitals, Teaching | 1 | 2010 | 52 | 0.080 |
Why?
| | Thyroglossal Cyst | 1 | 2009 | 4 | 0.080 |
Why?
| | Tongue Diseases | 1 | 2009 | 6 | 0.080 |
Why?
| | Medical Records | 1 | 2010 | 85 | 0.080 |
Why?
| | United States | 5 | 2025 | 5413 | 0.080 |
Why?
| | Vincristine | 1 | 2009 | 89 | 0.070 |
Why?
| | Calcitonin | 1 | 2009 | 30 | 0.070 |
Why?
| | Blood Flow Velocity | 2 | 2020 | 99 | 0.070 |
Why?
| | Sensory Thresholds | 1 | 2009 | 15 | 0.070 |
Why?
| | Granulation Tissue | 1 | 2009 | 9 | 0.070 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2009 | 71 | 0.070 |
Why?
| | Rhinitis | 1 | 2009 | 28 | 0.070 |
Why?
| | Lymphotoxin-alpha | 1 | 2009 | 7 | 0.070 |
Why?
| | Societies, Medical | 2 | 2025 | 207 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2010 | 281 | 0.070 |
Why?
| | Physical Examination | 1 | 2009 | 96 | 0.070 |
Why?
| | Sinusitis | 1 | 2009 | 43 | 0.070 |
Why?
| | Mucous Membrane | 1 | 2009 | 32 | 0.070 |
Why?
| | Turner Syndrome | 1 | 2008 | 15 | 0.070 |
Why?
| | Thyroidectomy | 1 | 2009 | 61 | 0.070 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 104 | 0.070 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 211 | 0.070 |
Why?
| | Transplantation, Homologous | 1 | 2009 | 154 | 0.070 |
Why?
| | X-Ray Intensifying Screens | 1 | 2008 | 3 | 0.070 |
Why?
| | Ear Diseases | 1 | 2008 | 28 | 0.070 |
Why?
| | Vasodilation | 2 | 2000 | 100 | 0.070 |
Why?
| | Burns, Electric | 1 | 2008 | 2 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 291 | 0.070 |
Why?
| | Shock, Septic | 1 | 2009 | 71 | 0.070 |
Why?
| | Fires | 1 | 2008 | 16 | 0.070 |
Why?
| | Suction | 1 | 2008 | 22 | 0.070 |
Why?
| | Gastrointestinal Hemorrhage | 2 | 2022 | 91 | 0.070 |
Why?
| | Cerebral Angiography | 1 | 2008 | 94 | 0.070 |
Why?
| | Intracranial Aneurysm | 1 | 2008 | 47 | 0.070 |
Why?
| | Sleep Apnea Syndromes | 1 | 2008 | 34 | 0.070 |
Why?
| | Photomicrography | 1 | 2007 | 6 | 0.070 |
Why?
| | Hospitals, Pediatric | 2 | 2019 | 243 | 0.060 |
Why?
| | Factor VII | 1 | 2007 | 3 | 0.060 |
Why?
| | Neoplasm Staging | 1 | 2010 | 774 | 0.060 |
Why?
| | Mouth Floor | 1 | 2007 | 5 | 0.060 |
Why?
| | Polyvinyl Alcohol | 1 | 2007 | 11 | 0.060 |
Why?
| | Postoperative Care | 1 | 2008 | 109 | 0.060 |
Why?
| | Collateral Circulation | 1 | 2007 | 39 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2007 | 67 | 0.060 |
Why?
| | Intraoperative Complications | 1 | 2008 | 114 | 0.060 |
Why?
| | Auditory Cortex | 1 | 2006 | 19 | 0.060 |
Why?
| | Patient Satisfaction | 1 | 2008 | 292 | 0.060 |
Why?
| | Therapy, Computer-Assisted | 1 | 2006 | 33 | 0.060 |
Why?
| | Thalamus | 1 | 2006 | 33 | 0.060 |
Why?
| | Arousal | 1 | 2006 | 104 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 1 | 2025 | 8 | 0.060 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 20 | 0.060 |
Why?
| | Psychomotor Performance | 1 | 2006 | 126 | 0.060 |
Why?
| | Lymphangiogenesis | 1 | 2025 | 8 | 0.060 |
Why?
| | Phenotype | 2 | 2019 | 803 | 0.060 |
Why?
| | Otoscopy | 1 | 2025 | 9 | 0.060 |
Why?
| | Swine | 1 | 2007 | 440 | 0.060 |
Why?
| | Reaction Time | 1 | 2006 | 207 | 0.060 |
Why?
| | Attention | 1 | 2006 | 169 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2025 | 869 | 0.060 |
Why?
| | Preoperative Care | 1 | 2007 | 173 | 0.060 |
Why?
| | Radiopharmaceuticals | 1 | 2006 | 198 | 0.060 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2006 | 182 | 0.060 |
Why?
| | Chronic Disease | 3 | 2016 | 581 | 0.060 |
Why?
| | Fibroblast Growth Factors | 2 | 2002 | 52 | 0.060 |
Why?
| | DNA, Complementary | 2 | 2002 | 128 | 0.050 |
Why?
| | Emergency Service, Hospital | 1 | 2009 | 530 | 0.050 |
Why?
| | Advisory Committees | 1 | 2025 | 75 | 0.050 |
Why?
| | Positron-Emission Tomography | 1 | 2006 | 299 | 0.050 |
Why?
| | Craniofacial Abnormalities | 1 | 2024 | 27 | 0.050 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2024 | 102 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 1925 | 0.050 |
Why?
| | Mutation | 2 | 2019 | 1338 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2009 | 832 | 0.050 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2023 | 85 | 0.050 |
Why?
| | Otitis Media | 2 | 2016 | 36 | 0.050 |
Why?
| | Growth Differentiation Factor 2 | 1 | 2022 | 6 | 0.050 |
Why?
| | Sheep | 2 | 2000 | 99 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2025 | 1569 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 136 | 0.040 |
Why?
| | Registries | 1 | 2025 | 652 | 0.040 |
Why?
| | alpha-Fetoproteins | 1 | 2001 | 12 | 0.040 |
Why?
| | Esophagoscopes | 1 | 2020 | 1 | 0.040 |
Why?
| | Blood Coagulation Tests | 1 | 2020 | 18 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2020 | 65 | 0.040 |
Why?
| | Gastrostomy | 1 | 2020 | 56 | 0.040 |
Why?
| | Ligands | 1 | 2020 | 203 | 0.040 |
Why?
| | Risk | 1 | 2020 | 306 | 0.040 |
Why?
| | Exhalation | 1 | 2019 | 20 | 0.040 |
Why?
| | Hepatitis C | 1 | 2001 | 82 | 0.040 |
Why?
| | Embryonic Development | 1 | 2019 | 18 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 48 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2019 | 96 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2020 | 186 | 0.040 |
Why?
| | Income | 1 | 2019 | 106 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2019 | 124 | 0.040 |
Why?
| | Syndrome | 1 | 2019 | 248 | 0.040 |
Why?
| | Hemorrhage | 1 | 2020 | 226 | 0.040 |
Why?
| | Alcohol Drinking | 1 | 2001 | 241 | 0.040 |
Why?
| | Gene Expression | 1 | 2021 | 618 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2020 | 729 | 0.040 |
Why?
| | Pulmonary Circulation | 1 | 1998 | 27 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2018 | 38 | 0.030 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2018 | 9 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2001 | 246 | 0.030 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2001 | 213 | 0.030 |
Why?
| | Equipment Design | 2 | 2010 | 290 | 0.030 |
Why?
| | Fibrinogen | 1 | 2018 | 33 | 0.030 |
Why?
| | Lymphatic System | 1 | 2018 | 13 | 0.030 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 4 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 423 | 0.030 |
Why?
| | Tertiary Healthcare | 1 | 2017 | 15 | 0.030 |
Why?
| | Tissue Adhesives | 1 | 1997 | 15 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2017 | 41 | 0.030 |
Why?
| | Catheterization | 2 | 1996 | 95 | 0.030 |
Why?
| | Liver Neoplasms | 1 | 2001 | 347 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2017 | 53 | 0.030 |
Why?
| | Polyethylene Glycols | 1 | 1997 | 95 | 0.030 |
Why?
| | Transcription Factors | 1 | 2020 | 571 | 0.030 |
Why?
| | Haplotypes | 1 | 2017 | 96 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 274 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 184 | 0.030 |
Why?
| | Leg | 1 | 1996 | 123 | 0.030 |
Why?
| | Genotype | 1 | 2017 | 563 | 0.030 |
Why?
| | Triage | 1 | 2016 | 65 | 0.030 |
Why?
| | Arterial Occlusive Diseases | 1 | 1996 | 85 | 0.030 |
Why?
| | Pain | 1 | 2018 | 353 | 0.030 |
Why?
| | Thrombolytic Therapy | 1 | 1996 | 114 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1996 | 132 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 598 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 567 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 67 | 0.030 |
Why?
| | Software | 1 | 2017 | 280 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2017 | 505 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2016 | 141 | 0.030 |
Why?
| | Portasystemic Shunt, Surgical | 1 | 1994 | 6 | 0.030 |
Why?
| | Esophageal and Gastric Varices | 1 | 1994 | 18 | 0.030 |
Why?
| | Aged, 80 and over | 3 | 2015 | 3495 | 0.030 |
Why?
| | Job Application | 1 | 2014 | 12 | 0.030 |
Why?
| | Hypertension, Portal | 1 | 1994 | 23 | 0.030 |
Why?
| | Logistic Models | 1 | 2016 | 947 | 0.030 |
Why?
| | Personnel Selection | 1 | 2014 | 25 | 0.030 |
Why?
| | Personal Satisfaction | 1 | 2014 | 76 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 1994 | 112 | 0.020 |
Why?
| | Temporal Bone | 1 | 2013 | 40 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 502 | 0.020 |
Why?
| | Patient Care Team | 1 | 2015 | 278 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 1994 | 181 | 0.020 |
Why?
| | Patient Admission | 1 | 2013 | 81 | 0.020 |
Why?
| | Fibroblast Growth Factor 7 | 2 | 2002 | 4 | 0.020 |
Why?
| | Oximetry | 1 | 2013 | 65 | 0.020 |
Why?
| | Program Evaluation | 1 | 2014 | 359 | 0.020 |
Why?
| | Liposomes | 2 | 2002 | 55 | 0.020 |
Why?
| | Liver Transplantation | 1 | 1994 | 174 | 0.020 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2002 | 141 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 278 | 0.020 |
Why?
| | Transfection | 2 | 2002 | 359 | 0.020 |
Why?
| | Cell Division | 2 | 2002 | 289 | 0.020 |
Why?
| | Electrocardiography | 1 | 2013 | 272 | 0.020 |
Why?
| | Stents | 1 | 1994 | 376 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2013 | 299 | 0.020 |
Why?
| | Survival Rate | 2 | 2008 | 949 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 518 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2010 | 22 | 0.020 |
Why?
| | Suture Anchors | 1 | 2010 | 11 | 0.020 |
Why?
| | Blood Glucose | 1 | 2013 | 491 | 0.020 |
Why?
| | Fiber Optic Technology | 1 | 2010 | 14 | 0.020 |
Why?
| | Safety | 1 | 2010 | 78 | 0.020 |
Why?
| | Prolapse | 1 | 2009 | 7 | 0.020 |
Why?
| | Skin Diseases, Infectious | 1 | 1968 | 8 | 0.020 |
Why?
| | Eczema | 1 | 1968 | 12 | 0.020 |
Why?
| | Ear, Middle | 1 | 2008 | 19 | 0.020 |
Why?
| | Demography | 1 | 2009 | 91 | 0.020 |
Why?
| | Electric Power Supplies | 1 | 2008 | 1 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2008 | 43 | 0.020 |
Why?
| | Acute Disease | 1 | 2009 | 393 | 0.020 |
Why?
| | Drainage | 1 | 2008 | 92 | 0.020 |
Why?
| | Factor VIIa | 1 | 2007 | 8 | 0.020 |
Why?
| | Postoperative Hemorrhage | 1 | 2007 | 54 | 0.020 |
Why?
| | Brain Damage, Chronic | 1 | 1986 | 14 | 0.010 |
Why?
| | Angiomatosis | 1 | 1965 | 6 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2007 | 489 | 0.010 |
Why?
| | Anemia | 1 | 1965 | 76 | 0.010 |
Why?
| | Sex Factors | 2 | 2001 | 747 | 0.010 |
Why?
| | Skin Physiological Phenomena | 1 | 2002 | 16 | 0.010 |
Why?
| | Epidermis | 1 | 2002 | 32 | 0.010 |
Why?
| | Regeneration | 1 | 2002 | 83 | 0.010 |
Why?
| | Germany | 1 | 2001 | 26 | 0.010 |
Why?
| | Epidemiologic Studies | 1 | 2001 | 23 | 0.010 |
Why?
| | Age of Onset | 1 | 2001 | 109 | 0.010 |
Why?
| | Endothelin-1 | 1 | 2000 | 35 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 64 | 0.010 |
Why?
| | Hemodynamics | 1 | 2000 | 236 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1998 | 112 | 0.010 |
Why?
| | Blood Vessel Prosthesis | 1 | 1996 | 89 | 0.010 |
Why?
| | Lung | 1 | 1998 | 481 | 0.010 |
Why?
| | Hepatic Veins | 1 | 1994 | 5 | 0.010 |
Why?
| | Portacaval Shunt, Surgical | 1 | 1994 | 11 | 0.010 |
Why?
| | Portal Vein | 1 | 1994 | 27 | 0.010 |
Why?
| | Cause of Death | 1 | 1994 | 156 | 0.010 |
Why?
| | Germany, East | 1 | 1968 | 4 | 0.000 |
Why?
| | Dermatitis, Seborrheic | 1 | 1968 | 4 | 0.000 |
Why?
| | Dermatomycoses | 1 | 1968 | 17 | 0.000 |
Why?
| | Seasons | 1 | 1968 | 92 | 0.000 |
Why?
| | Dermatitis, Atopic | 1 | 1968 | 40 | 0.000 |
Why?
| | Personality Development | 1 | 1986 | 5 | 0.000 |
Why?
| | Education, Special | 1 | 1986 | 9 | 0.000 |
Why?
| | Social Adjustment | 1 | 1986 | 29 | 0.000 |
Why?
| | Psychological Tests | 1 | 1986 | 52 | 0.000 |
Why?
| | Intelligence | 1 | 1986 | 56 | 0.000 |
Why?
| | Intellectual Disability | 1 | 1986 | 129 | 0.000 |
Why?
| | Skin Diseases | 1 | 1965 | 117 | 0.000 |
Why?
| | Brain Injuries | 1 | 1986 | 160 | 0.000 |
Why?
| | Gastrointestinal Diseases | 1 | 1965 | 130 | 0.000 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 1986 | 182 | 0.000 |
Why?
|
|
Richter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|